Tadalafil 5 mg once daily for the treatment of Asian men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: Analyses of data pooled from three randomized, double‐blind, placebo‐controlled studies

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 4, 2015-04 ,pp. : 378-384

John Wiley & Sons Inc

Access to resources Recommend Favorite

Alfuzosin 10 mg Once Daily Increases the Chances of Successful Trial without Catheter after Acute Urinary Retention Secondary to Benign Prostate Hyperplasia

By  

Urologia Internationalis, Vol. 83, Iss. 1, 2009-07 ,pp. : 44-48

Karger

Access to resources Recommend Favorite

Impact of cardiovascular risk factors and related comorbid conditions and medical therapy reported at baseline on the treatment response to tadalafil 5 mg once‐daily in men with lower urinary tract symptoms associated with benign prostatic hyperplasia: an integrated analysis of four randomised, double‐blind, placebo‐controlled, clinical trials

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 12, 2015-12 ,pp. : 1496-1507

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sexual function in men with LUTS due to BPH receiving TAD/FIN coadministration

By  

THE JOURNAL OF SEXUAL MEDICINE, Vol. 12, Iss. 1, 2015-01 ,pp. : 129-138

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and Safety of Ebastine 20 mg Compared to Loratadine 10 mg Once Daily in the Treatment of Seasonal Allergic Rhinitis: A Randomized, Double-Blind, Placebo-Controlled Study

By  

International Archives of Allergy and Immunology, Vol. 133, Iss. 4, 2004-04 ,pp. : 371-379

Karger

Access to resources Recommend Favorite